These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28771831)

  • 1. Ciprofloxacin Pharmacokinetics in Clinical Canine Patients.
    Papich MG
    J Vet Intern Med; 2017 Sep; 31(5):1508-1513. PubMed ID: 28771831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
    Papich MG
    Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data.
    Burgess DS; Hall RG
    Clin Ther; 2007 Jul; 29(7):1421-7. PubMed ID: 17825693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs.
    KuKanich K; KuKanich B; Guess S; Heinrich E
    J Vet Intern Med; 2016; 30(1):108-15. PubMed ID: 26651022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation.
    Thuo N; Ungphakorn W; Karisa J; Muchohi S; Muturi A; Kokwaro G; Thomson AH; Maitland K
    J Antimicrob Chemother; 2011 Oct; 66(10):2336-45. PubMed ID: 21831986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHARMACOKINETICS OF SINGLE-DOSE ORALLY ADMINISTERED CIPROFLOXACIN IN CALIFORNIA SEA LIONS (ZALOPHUS CALIFORNIANUS).
    Barbosa L; Johnson SP; Papich MG; Gulland F
    J Zoo Wildl Med; 2015 Jun; 46(2):266-72. PubMed ID: 26056878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and dosage regimen of ciprofloxacin following single intramuscular administration in Teddy goats.
    Iqbal Z; Javed I; Basit A; Jan I; Khan AA
    Pak J Pharm Sci; 2011 Jan; 24(1):69-74. PubMed ID: 21190922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study.
    van Zanten AR; Polderman KH; van Geijlswijk IM; van der Meer GY; Schouten MA; Girbes AR
    J Crit Care; 2008 Sep; 23(3):422-30. PubMed ID: 18725050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Multi Drug Resistance Protein 4 (MRP4) Inhibition on the Pharmacokinetics and Pharmacodynamics of Ciprofloxacin in Normal and Rats with LPS-Induced Inflammation.
    Prasad VG; Achanta S; Tammineni YR; Alla GR; Thirtham MR; Rao GS
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):733-741. PubMed ID: 26458556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of enrofloxacin use in koalas (Phascolarctos cinereus) via population pharmacokinetics and Monte Carlo simulation.
    Black LA; Landersdorfer CB; Bulitta JB; Griffith JE; Govendir M
    J Vet Pharmacol Ther; 2014 Jun; 37(3):301-11. PubMed ID: 24219009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients.
    Abdulla A; Rogouti O; Hunfeld NGM; Endeman H; Dijkstra A; van Gelder T; Muller AE; de Winter BCM; Koch BCP
    Eur J Clin Pharmacol; 2020 Jul; 76(7):957-967. PubMed ID: 32307575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.
    Leroux S; Turner MA; Guellec CB; Hill H; van den Anker JN; Kearns GL; Jacqz-Aigrain E; Zhao W;
    Clin Pharmacokinet; 2015 Dec; 54(12):1273-85. PubMed ID: 26063050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic properties of enrofloxacin in southern crested caracaras (Caracara plancus).
    Waxman S; Prados AP; de Lucas J; San Andres MI; Sassaroli JC; Orozco M; Argibay H; Rodriguez C
    J Avian Med Surg; 2013 Sep; 27(3):180-6. PubMed ID: 24344508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic behavior of enrofloxacin and its metabolite ciprofloxacin in urutu pit vipers (Bothrops alternatus) after intramuscular administration.
    Waxman S; Prados AP; de Lucas JJ; San Andrés MI; Regner P; de Oliveira VC; de Roodt A; Rodríguez C
    J Zoo Wildl Med; 2014 Mar; 45(1):78-85. PubMed ID: 24712165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline pharmacokinetics and pharmacodynamics in dogs: dosage recommendations for treatment of meticillin-resistant Staphylococcus pseudintermedius infections.
    Maaland MG; Guardabassi L; Papich MG
    Vet Dermatol; 2014 Jun; 25(3):182-e47. PubMed ID: 24840325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after the injection of enrofloxacin to pigs.
    Messenger KM; Papich MG; Blikslager AT
    J Vet Pharmacol Ther; 2012 Oct; 35(5):452-9. PubMed ID: 21913941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POPULATION PHARMACOKINETICS OF ENROFLOXACIN AND ITS METABOLITE CIPROFLOXACIN IN THE GREEN SEA URCHIN (STRONGYLOCENTROTUS DROEBACHIENSIS) FOLLOWING INTRACOELOMIC AND IMMERSION ADMINISTRATION.
    Phillips BE; Harms CA; Lewbart GA; Lahner LL; Haulena M; Rosenberg JF; Papich MG
    J Zoo Wildl Med; 2016 Mar; 47(1):175-86. PubMed ID: 27010278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Support for higher ciprofloxacin AUC 24/MIC targets in treating Enterobacteriaceae bloodstream infection.
    Zelenitsky SA; Ariano RE
    J Antimicrob Chemother; 2010 Aug; 65(8):1725-32. PubMed ID: 20558470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and Pharmacodynamic Analyses of Ceftaroline in Adults with Cystic Fibrosis.
    Autry EB; Rybak JM; Leung NR; Gardner BM; Burgess DR; Anstead MI; Kuhn RJ
    Pharmacotherapy; 2016 Jan; 36(1):13-8. PubMed ID: 26748559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.